Novartis raises 2018 sales outlook as Entresto, Cosentyx accelerate

Swiss drugmaker Novartis raised its full-year sales outlook on Thursday, citing growing revenue from its Cosentyx psoriasis and arthritis drug as well as the performance of its heart failure medicine Entresto, whose third-quarter sales more than doubled.

https://ift.tt/2yvysuH support@endlesssupplies.biz (Endless Supplies .Biz) October 18, 2018 at 01:03AM